Kintor money grab, unacceptable
    Product 9/23/2024

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’§ pyrilutamide (topical) 0.5% 2x daily
    πŸ’§ pyrilutamide (topical) 1% 2x daily
    πŸ’§ Minoxidil (topical)
    πŸ’Š Finasteride (oral)
    the tone is 😞 negative with no significant results.

    Other terms

    Kintor's KX826 (pyrilutamide) is ineffective at 0.5% and overpriced at 1%, leading to user frustration and calls for fair pricing. Users suggest sticking with proven treatments like Minoxidil and Finasteride.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 176 results

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

      community What 3 months without fin& min doesπŸ˜”

      in Progress Pictures  261 upvotes 1 month ago
      Stopping minoxidil and finasteride for three months caused significant hair loss. The user resumed treatment with 2.5mg oral minoxidil and 0.6mg finasteride and plans to update on progress in three months.

      community Pyrilutamide Phase 3 on its way

      in Treatment  129 upvotes 3 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.

      community Fuck it, I’m ordering Pyri Topical

      in Product  12 upvotes 5 months ago
      A user plans to order Pyrilutamide for hair loss after losing ground on finasteride. Another user advises against buying from Hairliciously, suggesting Amazon instead.

      community RU-58841 Lung Disease Possibility | Chest pain, "heart issues", etc

      in Treatment  21 upvotes 9 months ago
      Some users of RU-58841 report cardiovascular symptoms like heart palpitations and chest tightness, which may be linked to its metabolites causing lung disease. The safety of RU-58841 is uncertain due to lack of long-term data and concerns about product purity, especially from gray market sources.

    Related Research

    5 / 5 results